Insights from eight years of adoption experience of transcatheter mitral valve repair in Germany: observed utilisation patterns and impact on overall mitral valve procedure volumes
Standard
Insights from eight years of adoption experience of transcatheter mitral valve repair in Germany: observed utilisation patterns and impact on overall mitral valve procedure volumes. / Schaefer, Andreas; Lubos, Edith; Pietzsch, Jan Benjamin; Pietzsch, Malte; Weber, Simon; Blankenberg, Stefan; Reichenspurner, Hermann; Schäfer, Ulrich; Conradi, Lenard.
in: EUROINTERVENTION, Jahrgang 14, Nr. 9, 12.10.2018, S. e981-e987.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Insights from eight years of adoption experience of transcatheter mitral valve repair in Germany: observed utilisation patterns and impact on overall mitral valve procedure volumes
AU - Schaefer, Andreas
AU - Lubos, Edith
AU - Pietzsch, Jan Benjamin
AU - Pietzsch, Malte
AU - Weber, Simon
AU - Blankenberg, Stefan
AU - Reichenspurner, Hermann
AU - Schäfer, Ulrich
AU - Conradi, Lenard
PY - 2018/10/12
Y1 - 2018/10/12
N2 - AIMS: The German healthcare system was among the first to introduce transcatheter mitral valve repair (TMVR) into routine care. The objective of this study was to analyse adoption and utilisation patterns and to estimate the impact of TMVR availability on mitral valve (MV) procedure volumes in the first eight years after commercialisation.METHODS AND RESULTS: Procedure volumes were collected from German Federal Statistics Office databases for TMVR and mitral valve surgery (MVS) from 2008-2015. Procedure volumes were stratified by age group (<65, 65-74, 75-84, ≥85 years). Overall procedure volumes grew from 14,525 to 24,898 (+71%). MVS procedures grew from 14,477 to 20,402 (+41%) (p=0.008). The proportion of TMVR procedures grew from 0.3% (48 procedures) to 18.1% (4,496 procedures) (p=0.008). In 2015, TMVR use reached 5%, 15%, 31%, and 68% of overall MV procedures in the studied age groups (<65, 65-74, 75-84, ≥85 years). MVS volumes grew in all age groups, with the highest increase in the age group <65 (+2,945).CONCLUSIONS: The availability of TMVR has contributed to a pronounced increase in MV procedure volumes in Germany. Simultaneously, MVS procedure volumes continued to grow substantially. The highest increase of TMVR was observed in elderly populations, suggesting referral of patients with MV disease previously left untreated.
AB - AIMS: The German healthcare system was among the first to introduce transcatheter mitral valve repair (TMVR) into routine care. The objective of this study was to analyse adoption and utilisation patterns and to estimate the impact of TMVR availability on mitral valve (MV) procedure volumes in the first eight years after commercialisation.METHODS AND RESULTS: Procedure volumes were collected from German Federal Statistics Office databases for TMVR and mitral valve surgery (MVS) from 2008-2015. Procedure volumes were stratified by age group (<65, 65-74, 75-84, ≥85 years). Overall procedure volumes grew from 14,525 to 24,898 (+71%). MVS procedures grew from 14,477 to 20,402 (+41%) (p=0.008). The proportion of TMVR procedures grew from 0.3% (48 procedures) to 18.1% (4,496 procedures) (p=0.008). In 2015, TMVR use reached 5%, 15%, 31%, and 68% of overall MV procedures in the studied age groups (<65, 65-74, 75-84, ≥85 years). MVS volumes grew in all age groups, with the highest increase in the age group <65 (+2,945).CONCLUSIONS: The availability of TMVR has contributed to a pronounced increase in MV procedure volumes in Germany. Simultaneously, MVS procedure volumes continued to grow substantially. The highest increase of TMVR was observed in elderly populations, suggesting referral of patients with MV disease previously left untreated.
KW - Aged
KW - Aged, 80 and over
KW - Cardiac Catheterization
KW - Germany
KW - Heart Valve Prosthesis Implantation
KW - Humans
KW - Middle Aged
KW - Mitral Valve/surgery
KW - Mitral Valve Insufficiency
KW - Treatment Outcome
U2 - 10.4244/EIJ-D-18-00403
DO - 10.4244/EIJ-D-18-00403
M3 - SCORING: Journal article
C2 - 30111523
VL - 14
SP - e981-e987
JO - EUROINTERVENTION
JF - EUROINTERVENTION
SN - 1774-024X
IS - 9
ER -